Mostrar el registro sencillo del ítem

Effectiveness of black tea versus placebo in subjects with hypercholesterolemia: A PRISMA systematic review and meta-analysis

dc.contributor.authorAraya - Quintanilla F.
dc.contributor.authorGutiérrez - Espinoza H.
dc.contributor.authorMoyano – Gálvez V.
dc.contributor.authorMuñoz – Yánez M.J.
dc.contributor.authorPavez L.
dc.contributor.authorGarcía K.
dc.date.accessioned2020-09-02T22:12:24Z
dc.date.available2020-09-02T22:12:24Z
dc.date.issued2019
dc.identifier10.1016/j.dsx.2019.05.019
dc.identifier.citation13, 3, 2250-2258
dc.identifier.issn18714021
dc.identifier.urihttps://hdl.handle.net/20.500.12728/3589
dc.descriptionAim: To determine if the black tea is more effective in serum lipid profile that placebo in subjects with hypercholesterolemia. Design: Systematic review with meta-analysis of randomized clinical trials (RCTs). Data sources: The databases Medline, Central, Embase, Lilacs, Cinahl, SPORTDiscus, and Web of Science were searched from inception up to January 2019. Eligibility criteria for selecting studies: RCTs that compared black tea versus placebo, that included serum lipid profile outcomes in subjects older than 18 years of age with hypercholesterolemia. Results: Seven RCTs met the eligibility criteria, and for the quantitative synthesis, six studies were included. Mean difference for total cholesterol was 1.67 mg/dl 95% CI = −5.47 to 8.80 (p = 0.65), mean difference 0.28 mg/dl, 95% CI = −3.89 to 4.45 (p = 0.90) for triglycerides, mean difference 3.21 mg/dl, 95% CI = −11.02 to 4.60 (p = 0.42) for low density lipoprotein-cholesterol, mean difference 0.38 mg/dl, 95% CI = −1.12 to 1.87 (p = 0.62) for high density lipoprotein-cholesterol. Conclusion: In the short term, no significant differences were found in lipid serum profile comparing black tea consumption with placebo. © 2019 Diabetes India
dc.language.isoen
dc.publisherElsevier Ltd
dc.subjectBlack tea
dc.subjectHypercholesterolemia
dc.subjectMeta-analysis
dc.subjectSerum lipids
dc.subjectSystematic review
dc.subjectblack tea extract
dc.subjectcholesterol
dc.subjecthigh density lipoprotein cholesterol
dc.subjectlow density lipoprotein cholesterol
dc.subjectplacebo
dc.subjecttriacylglycerol
dc.subjectlipid
dc.subjectcholesterol blood level
dc.subjectCinahl
dc.subjectclinical assessment
dc.subjectclinical effectiveness
dc.subjectcomparative study
dc.subjectEmbase
dc.subjecthuman
dc.subjecthypercholesterolemia
dc.subjectlipid blood level
dc.subjectMedline
dc.subjectmeta analysis
dc.subjectoutcome assessment
dc.subjectpriority journal
dc.subjectquantitative analysis
dc.subjectrandomized controlled trial (topic)
dc.subjectReview
dc.subjectsystematic review
dc.subjecttea
dc.subjectWeb of Science
dc.subjectblood
dc.subjecthypercholesterolemia
dc.subjectprognosis
dc.subjectHumans
dc.subjectHypercholesterolemia
dc.subjectLipids
dc.subjectPrognosis
dc.subjectTea
dc.titleEffectiveness of black tea versus placebo in subjects with hypercholesterolemia: A PRISMA systematic review and meta-analysis
dc.typeReview


Ficheros en el ítem

Thumbnail
Nombre:
item_2-s2.0-85066299157.pdf
Tamaño:
3.255Kb
Formato:
PDF
Ver/

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem